UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

The relative contributions of ecstasy and cannabis to cognitive impairment.

Croft, RJ; Mackay, AJ; Mills, AT; Gruzelier, JG; (2001) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology (Berl) , 153 (3) 373 - 379.

Full text not available from this repository.

Abstract

(+/-)-3,4-methylenedioxymethamphet-amine (MDMA; 'ecstasy'), a commonly used recreational drug, has typically been found to be related to poor cognitive function in humans. However, cannabis consumption may not have been adequately controlled for in these studies.

Type:Article
Title:The relative contributions of ecstasy and cannabis to cognitive impairment.
Location:Germany
Language:English
Keywords:Adolescent, Adult, Analysis of Variance, Cognition, Cognition Disorders, Dronabinol, Female, Hallucinogens, Humans, Male, Memory, N-Methyl-3,4-methylenedioxyamphetamine, Neuropsychological Tests
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of)

Archive Staff Only: edit this record